Antidepressant use prior to traumatic brain injury was not associated with worse short-term outcomes for individuals ...
More than one-third of patients with cutaneous chronic graft-versus-host disease had a perception of treatment response that ...
Offspring of women aged 35 years or older vs. 25 to 29 years at childbirth were less likely to have food allergy reactions, ...
Political ideology is linked to Americans’ trust in scientists as sources of cancer information, study results suggest.A ...
Patients with idiopathic pulmonary fibrosis-associated chronic cough who received twice-daily oral extended release ...
A health care tool for an overlooked public health problemFear of needles is one of health care’s most common, and most ignored, barriers.
Abbreviated dual antiplatelet therapy after percutaneous coronary intervention using third-generation stents remained noninferior vs. 12-month DAPT for non-ST-segment elevation myocardial infarction ...
The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics. Yuvezzi ...
In this video, Shikha Saxena, MD, attending physician of the division of pulmonary and sleep medicine at the Children's ...
In this video, Shikha Saxena, MD, attending physician of the division of pulmonary and sleep medicine at the Children's ...
A Change.org petition with more than 800 signatures is calling on the FDA to approve low-dose atropine to slow the ...
In this video, Shikha Saxena, MD, attending physician of the division of pulmonary and sleep medicine at the Children's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results